WILMINGTON, Mass.—(BUSINESS WIRE)—Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously announced acquisition of Cognate BioServices, Inc. for approximately…
– Significantly Expands Charles River’s Scientific Capabilities in the High-Growth Cell and Gene Therapy Sector –
– Combines Cognate’s Comprehensive Cell and Gene Therapy CDMO…
DURHAM, North Carolina(GLOBE NEWSWIRE)—Bioventus Inc. (“Bioventus” or the “Company”) today announced the pricing of its initial public offering of 8,000,000 shares of Class A common…
WATERTOWN, Massachusetts (GLOBE NEWSWIRE)—EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with…
BOSTON, Massachusetts—PRNewswire—Haemonetics Corporation (NYSE: HAE) (“Haemonetics”), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that…
New York, NY –– EW Healthcare Partners (“EW”), a private equity firm dedicated to making growth equity investments in rapidly growing healthcare companies, announced the…
Robert S. White Joins Board of Directors
SANTA CLARA, California (GLOBE NEWSWIRE)—Cardiva Medical, Inc, an innovator in the field of vascular closure, today announced the…
Equity Financing Led by EW Healthcare Partners and Debt Financing Provided by Hayfin Capital Management. EW Healthcare Partners Managing Director and Co-Founder Martin Sutter and…
Providing large scale manufacturing capacity for AZD1222
Keele, UK, 16 June 2020: Cobra Biologics (Cobra), part of the Cognate BioServices family, an international CDMO for…